The pharmaceutical industry is under constant scrutiny, not just for the efficacy and safety of its products, but also for the compliance of its extended supply chains. As regulatory requirements evolve, so too does the complexity of managing third-party risks. In this landscape, organizations must adapt their strategies to ensure robust compliance across all facets of their operations. One company leading the charge in this transformation is REDE, which is redesigning legacy systems into...